Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Ingrid Schulman"'
Autor:
Seija Grénman, Anniina Färkkilä, Ingrid Schulman, Noora Andersson, Johanna Hynninen, Sampsa Hautaniemi, Olli Carpén, Kaisa Huhtinen, Kari Lavikka, Kaiyang Zhang, Rainer Lehtonen, Liina Salminen, Sakari Hietanen, Erika Ojanperä, Jaana Oikkonen
Publikováno v:
JCO Precision Oncology
PURPOSE Circulating tumor DNA (ctDNA) detection is a minimally invasive technique that offers dynamic molecular snapshots of genomic alterations in cancer. Although ctDNA markers can be used for early detection of cancers or for monitoring treatment
Autor:
Nil Campamà Sanz, Ingrid Schulman, Rainer Lehtonen, Antti Häkkinen, Mikko Kivikoski, Jaana Oikkonen, Sampsa Hautaniemi, Seija Grénman, Yilin Li, Johanna Hynninen, Kaisa Huhtinen, Sakari Hietanen
Publikováno v:
Clinical Cancer Research. 26:A60-A60
High-grade serous ovarian cancer (HGSOC) is the most common and difficult to treat ovarian cancer subtype. HGSOC is diagnosed typically at late stage when it has already metastasized to many tissues in peritoneal cavity. In order to gain understandin
Autor:
Kaiyang Zhang, Sampsa Hautaniemi, Anniina Färkkilä, Ingrid Schulman, Kaisa Huhtinen, Liina Salminen, Olli Carpén, Noora Andersson, Johanna Hynninen, Sakari Hietanen, Rainer Lehtonen, Seija Grénman, Jaana Oikkonen
Publikováno v:
Clinical Cancer Research. 25:GMM-043
Tumor cells leak their DNA into the blood stream, which allows detection of tumor mutations and copy number variants from circulating tumor DNA (ctDNA) from plasma samples. These variants offer a dynamic “molecular snapshot” to the changing lands